Norges Bank Amphastar Pharmaceuticals, Inc. Transaction History

Norges Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$22.96 - $36.45 $266,336 - $422,820	-11,600 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$18.14 - $23.29 $210,424 - $270,164	11,600 New	11,600 $270,000
Q3 2021 Nov 14, 2022	BUY	$17.83 - $21.49 $1.64 Million - $1.98 Million	92,200 New	92,200 $1.75 Million
Q3 2021 Nov 05, 2021	SELL	$17.83 - $21.49 $1.15 Million - $1.39 Million	-64,500 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$17.11 - $20.92 $1.1 Million - $1.35 Million	64,500 New	64,500 $1.3 Million
Q4 2019 Feb 12, 2020	SELL	$17.07 - $20.64 $426,750 - $516,000	-25,000 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$19.12 - $22.62 $478,000 - $565,500	25,000 New	25,000 $496,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.